These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10534967)

  • 1. Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?
    Salzman RT; Roberts MS; Wild J; Fabian C; Reder RF; Goldenheim PD
    J Pain Symptom Manage; 1999 Oct; 18(4):271-9. PubMed ID: 10534967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
    Hale M; Tudor IC; Khanna S; Thipphawong J
    Clin Ther; 2007 May; 29(5):874-888. PubMed ID: 17697906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain.
    Hale ME; Fleischmann R; Salzman R; Wild J; Iwan T; Swanton RE; Kaiko RF; Lacouture PG
    Clin J Pain; 1999 Sep; 15(3):179-83. PubMed ID: 10524470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain.
    Kaplan R; Parris WC; Citron ML; Zhukovsky D; Reder RF; Buckley BJ; Kaiko RF
    J Clin Oncol; 1998 Oct; 16(10):3230-7. PubMed ID: 9779696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate-release oral oxycodone in cancer pain patients.
    Stambaugh JE; Reder RF; Stambaugh MD; Stambaugh H; Davis M
    J Clin Pharmacol; 2001 May; 41(5):500-6. PubMed ID: 11361046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled-release oxycodone and morphine in cancer related pain.
    Heiskanen T; Kalso E
    Pain; 1997 Oct; 73(1):37-45. PubMed ID: 9414055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative analgesia with controlled-release oxycodone for outpatient anterior cruciate ligament surgery.
    Reuben SS; Connelly NR; Maciolek H
    Anesth Analg; 1999 Jun; 88(6):1286-91. PubMed ID: 10357331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain in Italian patients: results of an open-label, multicentre, observational study.
    Silvestri B; Bandieri E; Del Prete S; Ianniello GP; Micheletto G; Dambrosio M; Sabbatini G; Endrizzi L; Marra A; Aitini E; Calorio A; Garetto F; Nastasi G; Piantedosi F; Sidoti V; Spanu P
    Clin Drug Investig; 2008; 28(7):399-407. PubMed ID: 18544000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post hoc analyses of data from a 90-day clinical trial evaluating the tolerability and efficacy of tapentadol immediate release and oxycodone immediate release for the relief of moderate to severe pain in elderly and nonelderly patients.
    Vorsanger G; Xiang J; Biondi D; Upmalis D; Delfgaauw J; Allard R; Moskovitz B
    Pain Res Manag; 2011; 16(4):245-51. PubMed ID: 22059194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of study discontinuations with tapentadol inmmediate release and oxycodone immediate release in patients with low back or osteoarthritis pain.
    Vorsanger G; Xiang J; Okamoto A; Upmalis D; Moskovitz B
    J Opioid Manag; 2010; 6(3):169-79. PubMed ID: 20642246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe cancer pain.
    Pan H; Zhang Z; Zhang Y; Xu N; Lu L; Dou C; Guo Y; Wu S; Yue J; Wu D; Dai Y
    Clin Drug Investig; 2007; 27(4):259-67. PubMed ID: 17358098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Tolerability of Biphasic Immediate-Release/Extended-Release Oxycodone/Acetaminophen Tablets: Analysis of 11 Clinical Trials.
    Barrett T; Kostenbader K; Nalamachu S; Giuliani M; Young JL
    Pain Pract; 2016 Sep; 16(7):856-68. PubMed ID: 26296448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study.
    Portenoy RK; Farrar JT; Backonja MM; Cleeland CS; Yang K; Friedman M; Colucci SV; Richards P
    Clin J Pain; 2007 May; 23(4):287-99. PubMed ID: 17449988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
    Hale ME; Dvergsten C; Gimbel J
    J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes during opioid titration following initiation with or conversion to Remoxy®, an extended-release formulation of oxycodone.
    Roland CL; Setnik B; Cleveland JM; Brown DA
    Postgrad Med; 2011 Jul; 123(4):148-59. PubMed ID: 21680999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of controlled-release oxycodone for the treatment of chronic cancer pain: a randomized, double-blind study.
    Parris WC; Johnson BW; Croghan MK; Moore MR; Khojasteh A; Reder RF; Kaiko RF; Buckley BJ
    J Pain Symptom Manage; 1998 Oct; 16(4):205-11. PubMed ID: 9803047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study.
    Gabrail NY; Dvergsten C; Ahdieh H
    Curr Med Res Opin; 2004 Jun; 20(6):911-8. PubMed ID: 15200750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of oxycodone controlled-release immediately after NSAIDs: a new approach to obtain good pain control.
    Tessaro L; Bandieri E; Costa G; Fornasier G; Iorno V; Pizza C; Pastacaldi G; Micheletto G
    Eur Rev Med Pharmacol Sci; 2010 Feb; 14(2):113-21. PubMed ID: 20329570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of an extended-release oxycodone (Remoxy) formulation in patients with moderate to severe osteoarthritic pain.
    Friedmann N; Klutzaritz V; Webster L
    J Opioid Manag; 2011; 7(3):193-202. PubMed ID: 21823550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.